Selected research
Industry Research
Network Point-of-Care Glucose Testing Device Industry Research Report 2026
Market perspective
The global Network Point-of-Care Glucose Testing Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Network Point-of-Care Glucose Testing Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Network Point-of-Care Glucose Testing Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Network Point-of-Care Glucose Testing Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Network Point-of-Care Glucose Testing Device include Johnson & Johnson, Trividia Health, Inc., Terumo, Roche Holding AG, Prodigy Diabetes Care, Panasonic Healthcare Holdings, Omron, Nova Biomedical and Nipro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Network Point-of-Care Glucose Testing Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Network Point-of-Care Glucose Testing Device Market by Company
Johnson & Johnson
Trividia Health, Inc.
Terumo
Roche Holding AG
Prodigy Diabetes Care
Panasonic Healthcare Holdings
Omron
Nova Biomedical
Nipro
LifeScan, Inc.
EKF Diagnostics
Danaher Corporation
B. Braun
Ascensia Diabetes Care Holdings AG
AgaMatrix
ACON Laboratories, Inc.
77 Elektronika
Network Point-of-Care Glucose Testing Device Segment by Type
0.5uL/0.6uL
1.5uL
1uL
Others
Network Point-of-Care Glucose Testing Device Segment by Application
Clinic
Hospital
Household
Network Point-of-Care Glucose Testing Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Network Point-of-Care Glucose Testing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Network Point-of-Care Glucose Testing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Network Point-of-Care Glucose Testing Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Network Point-of-Care Glucose Testing Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Network Point-of-Care Glucose Testing Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Network Point-of-Care Glucose Testing Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5uL/0.6uL
- 1.5uL
- 1uL
- Others
Applications
- Clinic
- Hospital
- Household
Companies covered
- Johnson & Johnson
- Trividia Health, Inc.
- Terumo
- Roche Holding AG
- Prodigy Diabetes Care
- Panasonic Healthcare Holdings
- Omron
- Nova Biomedical
- Nipro
- LifeScan, Inc.
- EKF Diagnostics
- Danaher Corporation
- B. Braun
- Ascensia Diabetes Care Holdings AG
- AgaMatrix
- ACON Laboratories, Inc.
- 77 Elektronika
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Network Point-of-Care Glucose Testing Device Market Size (2021-2032)
- 2.2.2 Global Network Point-of-Care Glucose Testing Device Sales (2021-2032)
- 2.2.3 Global Network Point-of-Care Glucose Testing Device Market Average Price (2021-2032)
- 2.3 Network Point-of-Care Glucose Testing Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5uL/0.6uL
- 2.3.3 1.5uL
- 2.3.4 1uL
- 2.3.5 Others
- 2.4 Network Point-of-Care Glucose Testing Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Household
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Network Point-of-Care Glucose Testing Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Network Point-of-Care Glucose Testing Device Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Network Point-of-Care Glucose Testing Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Network Point-of-Care Glucose Testing Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Network Point-of-Care Glucose Testing Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Product Type & Application
- 3.8 Global Manufacturers of Network Point-of-Care Glucose Testing Device, Established Date
- 3.9 Global Network Point-of-Care Glucose Testing Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Trividia Health, Inc.
- 4.2.1 Trividia Health, Inc. Company Information
- 4.2.2 Trividia Health, Inc. Business Overview
- 4.2.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.2.5 Trividia Health, Inc. Recent Developments
- 4.3 Terumo
- 4.3.1 Terumo Company Information
- 4.3.2 Terumo Business Overview
- 4.3.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Terumo Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.3.5 Terumo Recent Developments
- 4.4 Roche Holding AG
- 4.4.1 Roche Holding AG Company Information
- 4.4.2 Roche Holding AG Business Overview
- 4.4.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.4.5 Roche Holding AG Recent Developments
- 4.5 Prodigy Diabetes Care
- 4.5.1 Prodigy Diabetes Care Company Information
- 4.5.2 Prodigy Diabetes Care Business Overview
- 4.5.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.5.5 Prodigy Diabetes Care Recent Developments
- 4.6 Panasonic Healthcare Holdings
- 4.6.1 Panasonic Healthcare Holdings Company Information
- 4.6.2 Panasonic Healthcare Holdings Business Overview
- 4.6.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.6.5 Panasonic Healthcare Holdings Recent Developments
- 4.7 Omron
- 4.7.1 Omron Company Information
- 4.7.2 Omron Business Overview
- 4.7.3 Omron Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Omron Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.7.5 Omron Recent Developments
- 4.8 Nova Biomedical
- 4.8.1 Nova Biomedical Company Information
- 4.8.2 Nova Biomedical Business Overview
- 4.8.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.8.5 Nova Biomedical Recent Developments
- 4.9 Nipro
- 4.9.1 Nipro Company Information
- 4.9.2 Nipro Business Overview
- 4.9.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nipro Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.9.5 Nipro Recent Developments
- 4.10 LifeScan, Inc.
- 4.10.1 LifeScan, Inc. Company Information
- 4.10.2 LifeScan, Inc. Business Overview
- 4.10.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.10.5 LifeScan, Inc. Recent Developments
- 4.11 EKF Diagnostics
- 4.11.1 EKF Diagnostics Company Information
- 4.11.2 EKF Diagnostics Business Overview
- 4.11.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.11.5 EKF Diagnostics Recent Developments
- 4.12 Danaher Corporation
- 4.12.1 Danaher Corporation Company Information
- 4.12.2 Danaher Corporation Business Overview
- 4.12.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.12.5 Danaher Corporation Recent Developments
- 4.13 B. Braun
- 4.13.1 B. Braun Company Information
- 4.13.2 B. Braun Business Overview
- 4.13.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.13.5 B. Braun Recent Developments
- 4.14 Ascensia Diabetes Care Holdings AG
- 4.14.1 Ascensia Diabetes Care Holdings AG Company Information
- 4.14.2 Ascensia Diabetes Care Holdings AG Business Overview
- 4.14.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.14.5 Ascensia Diabetes Care Holdings AG Recent Developments
- 4.15 AgaMatrix
- 4.15.1 AgaMatrix Company Information
- 4.15.2 AgaMatrix Business Overview
- 4.15.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.15.5 AgaMatrix Recent Developments
- 4.16 ACON Laboratories, Inc.
- 4.16.1 ACON Laboratories, Inc. Company Information
- 4.16.2 ACON Laboratories, Inc. Business Overview
- 4.16.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.16.5 ACON Laboratories, Inc. Recent Developments
- 4.17 77 Elektronika
- 4.17.1 77 Elektronika Company Information
- 4.17.2 77 Elektronika Business Overview
- 4.17.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolio
- 4.17.5 77 Elektronika Recent Developments
5 Global Network Point-of-Care Glucose Testing Device Market Scenario by Region
- 5.1 Global Network Point-of-Care Glucose Testing Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021-2032
- 5.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2021-2026
- 5.2.2 Global Network Point-of-Care Glucose Testing Device Sales by Region: 2027-2032
- 5.3 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2021-2032
- 5.3.1 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2021-2026
- 5.3.2 Global Network Point-of-Care Glucose Testing Device Revenue by Region: 2027-2032
- 5.4 North America Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
- 5.4.1 North America Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 5.4.3 North America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
- 5.5.1 Europe Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 5.5.3 Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
- 5.7.1 South America Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 5.7.3 South America Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Network Point-of-Care Glucose Testing Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Network Point-of-Care Glucose Testing Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032)
- 6.1.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2021-2032)
- 6.2 Global Network Point-of-Care Glucose Testing Device Revenue by Type (2021-2032)
- 6.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Network Point-of-Care Glucose Testing Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032)
- 7.1.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2021-2032)
- 7.2 Global Network Point-of-Care Glucose Testing Device Revenue by Application (2021-2032)
- 7.2.1 Global Network Point-of-Care Glucose Testing Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Network Point-of-Care Glucose Testing Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Network Point-of-Care Glucose Testing Device Value Chain Analysis
- 8.1.1 Network Point-of-Care Glucose Testing Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Network Point-of-Care Glucose Testing Device Production Mode & Process
- 8.2 Network Point-of-Care Glucose Testing Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Network Point-of-Care Glucose Testing Device Distributors
- 8.2.3 Network Point-of-Care Glucose Testing Device Customers
9 Global Network Point-of-Care Glucose Testing Device Analyzing Market Dynamics
- 9.1 Network Point-of-Care Glucose Testing Device Industry Trends
- 9.2 Network Point-of-Care Glucose Testing Device Industry Drivers
- 9.3 Network Point-of-Care Glucose Testing Device Industry Opportunities and Challenges
- 9.4 Network Point-of-Care Glucose Testing Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst